Difference between revisions of "Molecular Computing Patent Application Trends 2025"
Jump to navigation
Jump to search
Wikipatents (talk | contribs) (Updating Molecular Computing Patent Application Trends 2025) |
Wikipatents (talk | contribs) (Updating Molecular Computing Patent Application Trends 2025) |
||
| Line 1: | Line 1: | ||
== Molecular Computing Patent Application Filing Activity == | == Molecular Computing Patent Application Filing Activity == | ||
== Molecular Computing patent applications in 2025 == | == Molecular Computing patent applications in 2025 == | ||
| − | [[File:Molecular_Computing_Monthly_Patent_Applications_2025_- | + | [[File:Molecular_Computing_Monthly_Patent_Applications_2025_-_Up_to_February 2025.png|border|800px]] |
== Top Technology Areas in Molecular Computing == | == Top Technology Areas in Molecular Computing == | ||
| − | [[File:Top_Technology_Areas_in_Molecular_Computing_2025_- | + | [[File:Top_Technology_Areas_in_Molecular_Computing_2025_-_Up_to_February 2025.png|border|800px]] |
=== Top CPC Codes === | === Top CPC Codes === | ||
* [[:Category:CPC_A61K39/4611|A61K39/4611]] (No explanation available) | * [[:Category:CPC_A61K39/4611|A61K39/4611]] (No explanation available) | ||
| − | ** Count: | + | ** Count: 5 patents |
** Example: [[20250034229. METHODS OF TREATING EGFRVIII EXPRESSING GLIOBLASTOMAS (The Regents of the University of California)]] | ** Example: [[20250034229. METHODS OF TREATING EGFRVIII EXPRESSING GLIOBLASTOMAS (The Regents of the University of California)]] | ||
* [[:Category:CPC_A61K39/4631|A61K39/4631]] (No explanation available) | * [[:Category:CPC_A61K39/4631|A61K39/4631]] (No explanation available) | ||
| − | ** Count: | + | ** Count: 5 patents |
| + | ** Example: [[20250034229. METHODS OF TREATING EGFRVIII EXPRESSING GLIOBLASTOMAS (The Regents of the University of California)]] | ||
| + | * [[:Category:CPC_C07K14/7051|C07K14/7051]] (No explanation available) | ||
| + | ** Count: 3 patents | ||
** Example: [[20250034229. METHODS OF TREATING EGFRVIII EXPRESSING GLIOBLASTOMAS (The Regents of the University of California)]] | ** Example: [[20250034229. METHODS OF TREATING EGFRVIII EXPRESSING GLIOBLASTOMAS (The Regents of the University of California)]] | ||
* [[:Category:CPC_A61P35/00|A61P35/00]] (No explanation available) | * [[:Category:CPC_A61P35/00|A61P35/00]] (No explanation available) | ||
** Count: 3 patents | ** Count: 3 patents | ||
| − | |||
| − | |||
| − | |||
** Example: [[20250034229. METHODS OF TREATING EGFRVIII EXPRESSING GLIOBLASTOMAS (The Regents of the University of California)]] | ** Example: [[20250034229. METHODS OF TREATING EGFRVIII EXPRESSING GLIOBLASTOMAS (The Regents of the University of California)]] | ||
* [[:Category:CPC_A61K2239/31|A61K2239/31]] (No explanation available) | * [[:Category:CPC_A61K2239/31|A61K2239/31]] (No explanation available) | ||
| Line 25: | Line 25: | ||
** Count: 2 patents | ** Count: 2 patents | ||
** Example: [[20250034229. METHODS OF TREATING EGFRVIII EXPRESSING GLIOBLASTOMAS (The Regents of the University of California)]] | ** Example: [[20250034229. METHODS OF TREATING EGFRVIII EXPRESSING GLIOBLASTOMAS (The Regents of the University of California)]] | ||
| + | * [[:Category:CPC_A61K39/464412|A61K39/464412]] (No explanation available) | ||
| + | ** Count: 2 patents | ||
| + | ** Example: [[20250034251. ANTIBODY CHEMICALLY INDUCED DIMERIZER (ABCID) AS MOLECULAR SWITCHES FOR REGULATING CELLULAR THERAPIES (The Regents of the University of California)]] | ||
* [[:Category:CPC_C07K2317/92|C07K2317/92]] (No explanation available) | * [[:Category:CPC_C07K2317/92|C07K2317/92]] (No explanation available) | ||
** Count: 2 patents | ** Count: 2 patents | ||
** Example: [[20250034251. ANTIBODY CHEMICALLY INDUCED DIMERIZER (ABCID) AS MOLECULAR SWITCHES FOR REGULATING CELLULAR THERAPIES (The Regents of the University of California)]] | ** Example: [[20250034251. ANTIBODY CHEMICALLY INDUCED DIMERIZER (ABCID) AS MOLECULAR SWITCHES FOR REGULATING CELLULAR THERAPIES (The Regents of the University of California)]] | ||
| − | * [[:Category: | + | * [[:Category:CPC_C07K2319/02|C07K2319/02]] (No explanation available) |
| + | ** Count: 2 patents | ||
| + | ** Example: [[20250034251. ANTIBODY CHEMICALLY INDUCED DIMERIZER (ABCID) AS MOLECULAR SWITCHES FOR REGULATING CELLULAR THERAPIES (The Regents of the University of California)]] | ||
| + | * [[:Category:CPC_C07K2319/03|C07K2319/03]] (No explanation available) | ||
** Count: 2 patents | ** Count: 2 patents | ||
| − | ** Example: [[ | + | ** Example: [[20250034251. ANTIBODY CHEMICALLY INDUCED DIMERIZER (ABCID) AS MOLECULAR SWITCHES FOR REGULATING CELLULAR THERAPIES (The Regents of the University of California)]] |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
== Top Companies in Molecular Computing 2025 == | == Top Companies in Molecular Computing 2025 == | ||
| Line 66: | Line 66: | ||
* Recent patents: | * Recent patents: | ||
** [[20250042957. DESIGNED REPEAT DOMAINS WITH DUAL BINDING SPECIFICITY AND THEIR USE (Molecular Partners AG)]] (20250206) | ** [[20250042957. DESIGNED REPEAT DOMAINS WITH DUAL BINDING SPECIFICITY AND THEIR USE (Molecular Partners AG)]] (20250206) | ||
| + | === [[:Category:THE GENERAL HOSPITAL CORPORATION|THE GENERAL HOSPITAL CORPORATION]] === | ||
| + | * Number of Molecular Computing patents: 1 | ||
| + | * Top CPC codes: | ||
| + | ** [[:Category:CPC_C07K14/4702|C07K14/4702]] (No explanation available): 1 patents | ||
| + | ** [[:Category:CPC_A61K39/4611|A61K39/4611]] (No explanation available): 1 patents | ||
| + | ** [[:Category:CPC_A61K39/4631|A61K39/4631]] (No explanation available): 1 patents | ||
| + | * Recent patents: | ||
| + | ** [[20250074957. MOLECULAR SWITCH-MEDIATED CONTROL OF ENGINEERED CELLS (THE GENERAL HOSPITAL CORPORATION)]] (20250306) | ||
=== [[:Category:PRECIGEN, INC.|PRECIGEN, INC.]] === | === [[:Category:PRECIGEN, INC.|PRECIGEN, INC.]] === | ||
* Number of Molecular Computing patents: 1 | * Number of Molecular Computing patents: 1 | ||
| Line 92: | Line 100: | ||
* [[:Category:CPC_C12N2740/15041|C12N2740/15041]] (No explanation available) | * [[:Category:CPC_C12N2740/15041|C12N2740/15041]] (No explanation available) | ||
| − | |||
| − | |||
| − | |||
** Count: 1 patents | ** Count: 1 patents | ||
** Example: [[20250009801. COMBINATION OF MOLECULAR SWITCH REGULATION TYPE CHIMERIC ANTIGEN RECEPTOR CELL AND ANTIBODY, AND USE THEREOF (INNOVENT CELLS PHARMACEUTICALS (SU ZHOU) CO., LTD.)]] | ** Example: [[20250009801. COMBINATION OF MOLECULAR SWITCH REGULATION TYPE CHIMERIC ANTIGEN RECEPTOR CELL AND ANTIBODY, AND USE THEREOF (INNOVENT CELLS PHARMACEUTICALS (SU ZHOU) CO., LTD.)]] | ||
| Line 119: | Line 124: | ||
** Example: [[20250009801. COMBINATION OF MOLECULAR SWITCH REGULATION TYPE CHIMERIC ANTIGEN RECEPTOR CELL AND ANTIBODY, AND USE THEREOF (INNOVENT CELLS PHARMACEUTICALS (SU ZHOU) CO., LTD.)]] | ** Example: [[20250009801. COMBINATION OF MOLECULAR SWITCH REGULATION TYPE CHIMERIC ANTIGEN RECEPTOR CELL AND ANTIBODY, AND USE THEREOF (INNOVENT CELLS PHARMACEUTICALS (SU ZHOU) CO., LTD.)]] | ||
* [[:Category:CPC_C12Y401/01005|C12Y401/01005]] (No explanation available) | * [[:Category:CPC_C12Y401/01005|C12Y401/01005]] (No explanation available) | ||
| + | ** Count: 1 patents | ||
| + | ** Example: [[20250027093. MOLECULAR SWITCHES (PRECIGEN, INC.)]] | ||
| + | * [[:Category:CPC_C12Y401/01004|C12Y401/01004]] (No explanation available) | ||
** Count: 1 patents | ** Count: 1 patents | ||
** Example: [[20250027093. MOLECULAR SWITCHES (PRECIGEN, INC.)]] | ** Example: [[20250027093. MOLECULAR SWITCHES (PRECIGEN, INC.)]] | ||
| Line 125: | Line 133: | ||
[[File:Top_Companies_in_Emerging_Molecular_Computing_Technologies.png|border|800px]] | [[File:Top_Companies_in_Emerging_Molecular_Computing_Technologies.png|border|800px]] | ||
| − | * [[:Category:INNOVENT CELLS PHARMACEUTICALS (SU ZHOU) CO., LTD.|INNOVENT CELLS PHARMACEUTICALS (SU ZHOU) CO., LTD.]]: | + | * [[:Category:INNOVENT CELLS PHARMACEUTICALS (SU ZHOU) CO., LTD.|INNOVENT CELLS PHARMACEUTICALS (SU ZHOU) CO., LTD.]]: 8 patents |
| − | * [[:Category:PRECIGEN, INC.|PRECIGEN, INC.]]: | + | * [[:Category:PRECIGEN, INC.|PRECIGEN, INC.]]: 2 patents |
== Top Inventors in Molecular Computing == | == Top Inventors in Molecular Computing == | ||
| Line 261: | Line 269: | ||
* Recent patents: | * Recent patents: | ||
** [[20250042957. DESIGNED REPEAT DOMAINS WITH DUAL BINDING SPECIFICITY AND THEIR USE (Molecular Partners AG)]] (20250206) | ** [[20250042957. DESIGNED REPEAT DOMAINS WITH DUAL BINDING SPECIFICITY AND THEIR USE (Molecular Partners AG)]] (20250206) | ||
| + | === [[:Category:Max Jan|Max Jan of Boston MA (US)]] === | ||
| + | * Number of Molecular Computing patents: 1 | ||
| + | * Top companies: | ||
| + | ** [[:Category:THE GENERAL HOSPITAL CORPORATION|THE GENERAL HOSPITAL CORPORATION]]: 1 patents | ||
| + | * Recent patents: | ||
| + | ** [[20250074957. MOLECULAR SWITCH-MEDIATED CONTROL OF ENGINEERED CELLS (THE GENERAL HOSPITAL CORPORATION)]] (20250306) | ||
| + | === [[:Category:Quinlan L. Sievers|Quinlan L. Sievers of Boston MA (US)]] === | ||
| + | * Number of Molecular Computing patents: 1 | ||
| + | * Top companies: | ||
| + | ** [[:Category:THE GENERAL HOSPITAL CORPORATION|THE GENERAL HOSPITAL CORPORATION]]: 1 patents | ||
| + | * Recent patents: | ||
| + | ** [[20250074957. MOLECULAR SWITCH-MEDIATED CONTROL OF ENGINEERED CELLS (THE GENERAL HOSPITAL CORPORATION)]] (20250306) | ||
| + | === [[:Category:Benjamin Ebert|Benjamin Ebert of Boston MA (US)]] === | ||
| + | * Number of Molecular Computing patents: 1 | ||
| + | * Top companies: | ||
| + | ** [[:Category:THE GENERAL HOSPITAL CORPORATION|THE GENERAL HOSPITAL CORPORATION]]: 1 patents | ||
| + | * Recent patents: | ||
| + | ** [[20250074957. MOLECULAR SWITCH-MEDIATED CONTROL OF ENGINEERED CELLS (THE GENERAL HOSPITAL CORPORATION)]] (20250306) | ||
| + | === [[:Category:Marcela Maus|Marcela Maus of Boston MA (US)]] === | ||
| + | * Number of Molecular Computing patents: 1 | ||
| + | * Top companies: | ||
| + | ** [[:Category:THE GENERAL HOSPITAL CORPORATION|THE GENERAL HOSPITAL CORPORATION]]: 1 patents | ||
| + | * Recent patents: | ||
| + | ** [[20250074957. MOLECULAR SWITCH-MEDIATED CONTROL OF ENGINEERED CELLS (THE GENERAL HOSPITAL CORPORATION)]] (20250306) | ||
=== [[:Category:Mark Anton HELD|Mark Anton HELD of Germantown MD (US)]] === | === [[:Category:Mark Anton HELD|Mark Anton HELD of Germantown MD (US)]] === | ||
* Number of Molecular Computing patents: 1 | * Number of Molecular Computing patents: 1 | ||
| Line 330: | Line 362: | ||
* Germantown: 6 inventors | * Germantown: 6 inventors | ||
* Zürich-Schlieren: 5 inventors | * Zürich-Schlieren: 5 inventors | ||
| + | * Boston: 4 inventors | ||
[[Category:Molecular Computing]] | [[Category:Molecular Computing]] | ||
[[Category:Patent Application Trends by Technology in 2025]] | [[Category:Patent Application Trends by Technology in 2025]] | ||
Revision as of 03:05, 13 March 2025
Contents
- 1 Molecular Computing Patent Application Filing Activity
- 2 Molecular Computing patent applications in 2025
- 3 Top Technology Areas in Molecular Computing
- 4 Top Companies in Molecular Computing 2025
- 5 New Companies in Molecular Computing (Last Month)
- 6 Emerging Technology Areas in Molecular Computing
- 7 Top Companies in Emerging Molecular Computing Technologies 2025
- 8 Top Inventors in Molecular Computing
- 8.1 Wei XU
- 8.2 Huafeng WEI
- 8.3 Wendell A. Lim of San Francisco CA (US)
- 8.4 Hideho Okada of San Francisco CA (US)
- 8.5 Kole T. Roybal of San Francisco CA (US)
- 8.6 Joseph H. Choe of San Francisco CA (US)
- 8.7 Payal B. Watchmaker of San Francisco CA (US)
- 8.8 James A. WELLS of San Francisco CA (US)
- 8.9 Zachary B. HILL of San Francisco CA (US)
- 8.10 Alexander J. MARTINKO of San Francisco CA (US)
- 8.11 Diana Binia DAROWSKI
- 8.12 Dan XU
- 8.13 Ying YAO
- 8.14 Bianka PRINZ
- 8.15 Nadthakarn BOLAND
- 8.16 James GEOGHEGAN
- 8.17 Simon Fontaine
- 8.18 Andreas Bosshart
- 8.19 Bernd Schlereth
- 8.20 Daniel Steiner
- 8.21 Marcel Walser
- 8.22 Max Jan of Boston MA (US)
- 8.23 Quinlan L. Sievers of Boston MA (US)
- 8.24 Benjamin Ebert of Boston MA (US)
- 8.25 Marcela Maus of Boston MA (US)
- 8.26 Mark Anton HELD of Germantown MD (US)
- 8.27 Xinhua ZHAO of Germantown MD (US)
- 8.28 Lily Yuin CHAO of Germantown MD (US)
- 8.29 Na TRINH of Germantown MD (US)
- 8.30 James KEALEY of Germantown MD (US)
- 8.31 Kevin Lee DIETZEL of Germantown MD (US)
- 8.32 Shengjie GUO
- 8.33 Jianan CHEN
- 8.34 Guozhi CHEN
- 9 Top Collaborations in Molecular Computing
- 10 Top US States for Molecular Computing Inventors
- 11 Top Cities for Molecular Computing Inventors
Molecular Computing Patent Application Filing Activity
Molecular Computing patent applications in 2025
Top Technology Areas in Molecular Computing
Top CPC Codes
- A61K39/4611 (No explanation available)
- A61K39/4631 (No explanation available)
- C07K14/7051 (No explanation available)
- A61P35/00 (No explanation available)
- A61K2239/31 (No explanation available)
- A61K2239/38 (No explanation available)
- A61K39/464412 (No explanation available)
- C07K2317/92 (No explanation available)
- C07K2319/02 (No explanation available)
- C07K2319/03 (No explanation available)
Top Companies in Molecular Computing 2025
The Regents of the University of California
- Number of Molecular Computing patents: 2
- Top CPC codes:
- A61K39/4611 (No explanation available): 2 patents
- A61K39/4631 (No explanation available): 2 patents
- C07K14/7051 (No explanation available): 1 patents
- Recent patents:
INNOVENT CELLS PHARMACEUTICALS (SUZHOU) CO., LTD.
- Number of Molecular Computing patents: 1
- Top CPC codes:
- A61K39/464402 (No explanation available): 1 patents
- A61K39/4611 (No explanation available): 1 patents
- A61K39/4631 (No explanation available): 1 patents
- Recent patents:
Molecular Partners AG
- Number of Molecular Computing patents: 1
- Top CPC codes:
- Recent patents:
THE GENERAL HOSPITAL CORPORATION
- Number of Molecular Computing patents: 1
- Top CPC codes:
- C07K14/4702 (No explanation available): 1 patents
- A61K39/4611 (No explanation available): 1 patents
- A61K39/4631 (No explanation available): 1 patents
- Recent patents:
PRECIGEN, INC.
- Number of Molecular Computing patents: 1
- Top CPC codes:
- C12N15/52 (No explanation available): 1 patents
- C12N1/20 (No explanation available): 1 patents
- C12N9/0006 (No explanation available): 1 patents
- Recent patents:
INNOVENT CELLS PHARMACEUTICALS (SU ZHOU) CO., LTD.
- Number of Molecular Computing patents: 1
- Top CPC codes:
- A61K35/17 (No explanation available): 1 patents
- A61K39/4611 (No explanation available): 1 patents
- A61K39/4631 (No explanation available): 1 patents
- Recent patents:
New Companies in Molecular Computing (Last Month)
No new companies detected in the last month.
Emerging Technology Areas in Molecular Computing
- C12N2740/15041 (No explanation available)
- A61K2239/22 (No explanation available)
- A61K2239/21 (No explanation available)
- A61K2239/17 (No explanation available)
- A61K2239/13 (No explanation available)
- C12N15/86 (No explanation available)
- C07K16/28 (No explanation available)
- A61K35/17 (No explanation available)
- C12Y401/01005 (No explanation available)
- Count: 1 patents
- Example: 20250027093. MOLECULAR SWITCHES (PRECIGEN, INC.)
- C12Y401/01004 (No explanation available)
- Count: 1 patents
- Example: 20250027093. MOLECULAR SWITCHES (PRECIGEN, INC.)
Top Companies in Emerging Molecular Computing Technologies 2025
- INNOVENT CELLS PHARMACEUTICALS (SU ZHOU) CO., LTD.: 8 patents
- PRECIGEN, INC.: 2 patents
Top Inventors in Molecular Computing
Wei XU
- Number of Molecular Computing patents: 2
- Top companies:
- Recent patents:
- 20250041416. P329G ANTIBODY TARGETING BCMA, COMBINATION OF SAME WITH CHIMERIC ANTIGEN RECEPTOR CELL, AND USE THEREOF (INNOVENT CELLS PHARMACEUTICALS (SUZHOU) CO., LTD.) (20250206)
- 20250009801. COMBINATION OF MOLECULAR SWITCH REGULATION TYPE CHIMERIC ANTIGEN RECEPTOR CELL AND ANTIBODY, AND USE THEREOF (INNOVENT CELLS PHARMACEUTICALS (SU ZHOU) CO., LTD.) (20250109)
Huafeng WEI
- Number of Molecular Computing patents: 2
- Top companies:
- Recent patents:
- 20250041416. P329G ANTIBODY TARGETING BCMA, COMBINATION OF SAME WITH CHIMERIC ANTIGEN RECEPTOR CELL, AND USE THEREOF (INNOVENT CELLS PHARMACEUTICALS (SUZHOU) CO., LTD.) (20250206)
- 20250009801. COMBINATION OF MOLECULAR SWITCH REGULATION TYPE CHIMERIC ANTIGEN RECEPTOR CELL AND ANTIBODY, AND USE THEREOF (INNOVENT CELLS PHARMACEUTICALS (SU ZHOU) CO., LTD.) (20250109)
Wendell A. Lim of San Francisco CA (US)
- Number of Molecular Computing patents: 1
- Top companies:
- The Regents of the University of California: 1 patents
- Recent patents:
Hideho Okada of San Francisco CA (US)
- Number of Molecular Computing patents: 1
- Top companies:
- The Regents of the University of California: 1 patents
- Recent patents:
Kole T. Roybal of San Francisco CA (US)
- Number of Molecular Computing patents: 1
- Top companies:
- The Regents of the University of California: 1 patents
- Recent patents:
Joseph H. Choe of San Francisco CA (US)
- Number of Molecular Computing patents: 1
- Top companies:
- The Regents of the University of California: 1 patents
- Recent patents:
Payal B. Watchmaker of San Francisco CA (US)
- Number of Molecular Computing patents: 1
- Top companies:
- The Regents of the University of California: 1 patents
- Recent patents:
James A. WELLS of San Francisco CA (US)
- Number of Molecular Computing patents: 1
- Top companies:
- The Regents of the University of California: 1 patents
- Recent patents:
Zachary B. HILL of San Francisco CA (US)
- Number of Molecular Computing patents: 1
- Top companies:
- The Regents of the University of California: 1 patents
- Recent patents:
Alexander J. MARTINKO of San Francisco CA (US)
- Number of Molecular Computing patents: 1
- Top companies:
- The Regents of the University of California: 1 patents
- Recent patents:
Diana Binia DAROWSKI
- Number of Molecular Computing patents: 1
- Top companies:
- Recent patents:
Dan XU
- Number of Molecular Computing patents: 1
- Top companies:
- Recent patents:
Ying YAO
- Number of Molecular Computing patents: 1
- Top companies:
- Recent patents:
Bianka PRINZ
- Number of Molecular Computing patents: 1
- Top companies:
- Recent patents:
Nadthakarn BOLAND
- Number of Molecular Computing patents: 1
- Top companies:
- Recent patents:
James GEOGHEGAN
- Number of Molecular Computing patents: 1
- Top companies:
- Recent patents:
Simon Fontaine
- Number of Molecular Computing patents: 1
- Top companies:
- Molecular Partners AG: 1 patents
- Recent patents:
Andreas Bosshart
- Number of Molecular Computing patents: 1
- Top companies:
- Molecular Partners AG: 1 patents
- Recent patents:
Bernd Schlereth
- Number of Molecular Computing patents: 1
- Top companies:
- Molecular Partners AG: 1 patents
- Recent patents:
Daniel Steiner
- Number of Molecular Computing patents: 1
- Top companies:
- Molecular Partners AG: 1 patents
- Recent patents:
Marcel Walser
- Number of Molecular Computing patents: 1
- Top companies:
- Molecular Partners AG: 1 patents
- Recent patents:
Max Jan of Boston MA (US)
- Number of Molecular Computing patents: 1
- Top companies:
- THE GENERAL HOSPITAL CORPORATION: 1 patents
- Recent patents:
Quinlan L. Sievers of Boston MA (US)
- Number of Molecular Computing patents: 1
- Top companies:
- THE GENERAL HOSPITAL CORPORATION: 1 patents
- Recent patents:
Benjamin Ebert of Boston MA (US)
- Number of Molecular Computing patents: 1
- Top companies:
- THE GENERAL HOSPITAL CORPORATION: 1 patents
- Recent patents:
Marcela Maus of Boston MA (US)
- Number of Molecular Computing patents: 1
- Top companies:
- THE GENERAL HOSPITAL CORPORATION: 1 patents
- Recent patents:
Mark Anton HELD of Germantown MD (US)
- Number of Molecular Computing patents: 1
- Top companies:
- PRECIGEN, INC.: 1 patents
- Recent patents:
Xinhua ZHAO of Germantown MD (US)
- Number of Molecular Computing patents: 1
- Top companies:
- PRECIGEN, INC.: 1 patents
- Recent patents:
Lily Yuin CHAO of Germantown MD (US)
- Number of Molecular Computing patents: 1
- Top companies:
- PRECIGEN, INC.: 1 patents
- Recent patents:
Na TRINH of Germantown MD (US)
- Number of Molecular Computing patents: 1
- Top companies:
- PRECIGEN, INC.: 1 patents
- Recent patents:
James KEALEY of Germantown MD (US)
- Number of Molecular Computing patents: 1
- Top companies:
- PRECIGEN, INC.: 1 patents
- Recent patents:
Kevin Lee DIETZEL of Germantown MD (US)
- Number of Molecular Computing patents: 1
- Top companies:
- PRECIGEN, INC.: 1 patents
- Recent patents:
Shengjie GUO
- Number of Molecular Computing patents: 1
- Top companies:
- Recent patents:
Jianan CHEN
- Number of Molecular Computing patents: 1
- Top companies:
- Recent patents:
Guozhi CHEN
- Number of Molecular Computing patents: 1
- Top companies:
- Recent patents:
Top Collaborations in Molecular Computing
Top US States for Molecular Computing Inventors
Top Cities for Molecular Computing Inventors
- Suzhou, Jiangsu: 13 inventors
- San Francisco: 8 inventors
- Germantown: 6 inventors
- Zürich-Schlieren: 5 inventors
- Boston: 4 inventors
